<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7493736/table_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 3</label>
  <p>Summarized concentrations of phenothiazines inhibiting RNA virus replication.</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">Virus</th>
   <th colspan="1" rowspan="1" id="0-1-.">Drug</th>
   <th colspan="1" rowspan="1" id="0-2-.">Concentration inhibiting viral replication [μM]</th>
   <th colspan="1" rowspan="1" id="0-3-.">Source</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left">DENV-2</td>
   <td align="left">Prochlorperazine</td>
   <td align="left">EC 
    <sub>50</sub> = 137 nM 
   </td>
   <td align="left">
    <a rid="bib53" ref-type="bibr">Simanjuntak et al. (2015)</a>
   </td>
  </tr>
  <tr>
   <td align="left">MERS-CoV</td>
   <td align="left">Chlorpromazine</td>
   <td align="left">12 μM (complete inhibition)</td>
   <td align="left">(Wilde et al. 2014)</td>
  </tr>
  <tr>
   <td align="left">SINV</td>
   <td align="left">Thioridazine</td>
   <td align="left">IC 
    <sub>50</sub> = 37.3 μM 
   </td>
   <td align="left">
    <a rid="bib47" ref-type="bibr">Pohjala et al. (2011)</a>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="3">SFV</td>
   <td align="left">Chlorpromazine</td>
   <td align="left">IC 
    <sub>50</sub> = 15.7 μM 
   </td>
   <td align="left">
    <a rid="bib47" ref-type="bibr">Pohjala et al. (2011)</a>
   </td>
  </tr>
  <tr>
   <td align="left">Perphenazine</td>
   <td align="left">IC 
    <sub>50</sub> = 25.1 μM 
   </td>
   <td align="left">
    <a rid="bib47" ref-type="bibr">Pohjala et al. (2011)</a>
   </td>
  </tr>
  <tr>
   <td align="left">Thioridazine</td>
   <td align="left">IC 
    <sub>50</sub> = 14.9 μM and 19.3 μM 
   </td>
   <td align="left">
    <a rid="bib47" ref-type="bibr">Pohjala et al. (2011)</a>
   </td>
  </tr>
  <tr>
   <td align="left">ZEBOV-GFP</td>
   <td align="left">Chlorpromazine</td>
   <td align="left">10 μg/ml i.e. 31.36 μM (complete inhibition)</td>
   <td align="left">
    <a rid="bib4" ref-type="bibr">Bhattacharyya et al. (2010)</a>
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>DENV-2 - Dengue virus serotype 2, MERS - Middle East respiratory syndrome, SFV - Semliki Forest virus, SINV - Sindbis virus, ZEBOV - GFP-expressing replication-competent EBOV Zaire.</p>
  </p>
 </tfoot>
</table>
